bone mineral density assessment may be performed at the commencement of treatment for osteoporosis and then subsequently after more than 18 months on treatment (1)
quantitation of urinary deoxypyridinoline/creatinine ratio to quantify bone turnover, initially, then whilst on treatment
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.